This Deadly Bacteria Lives on Your Skin (why you should care)

Move over MRSA and E-coli., there is a new bacteria in town, and it is becoming increasingly deadly due to antibiotic resistance. Here is the worst part, this bacteria is present on the skin of every human being.

According to researchers at the Milner Center of Evolution at the University of Bath caution that this organism should not be taken lightly and more precautions need to be made for those at higher risk of infection after surgery.

Trying to understand strains of S. epidermidis

Scientists hope that a better understanding of some of the various strains of S. epidermidis promote diseases in some cases that they might be able to identify high-risk patients before they go into surgery.

To do this, researchers took samples of patients who had developed infections after hip or knees joint replacement and fracture operations and compared them with samples they had taken from the skin of some healthy volunteers.

Although the identified 61 genes of disease-causing bacteria were not present in most of the samples from the healthy volunteers, there was a surprise.  A deadly form of the bacteria was found on some of the healthy volunteers

Study leaders speak out

According to Professor Sam Sheppard, Director of Bionformatics at the Miler Center fore Evloution at the University of Bath had this to say.

Infections after surgery are severe and can be fatal. According to study leaders, the infection causes almost a third of deaths in the United Kingdom. Identifying those that are at highest risk before surgery allows for extra precautions to be taken.

Not controlling this bug can lead to rapid evolution and the disease-causing genes could get out of control and spread like wildfire. This means that infections after surgery could become more prevalent.

Sadly joint replacement surgery can help patients live a more pain free life, but they could also expose them to deadly infection from S. epidermidis.

This study is a key to future protection and hopefully will spur further research that will help to protect patients in the future.